1. Introduction
===============

The genus *Tagetes* (Asteraceae) is mainly native to the central and southern part of America. It consists of approximately 30 species \[[@B1-molecules-19-02819]\]. Members of the genus *Tagetes* have a long history of human use as beverages, condiments, ornamentals, and medicinal decoctions. *Tagetes minuta* L. has been used as anthelmintic, diuretic, antispasmodic, and for treatment of stomach and intestinal diseases \[[@B2-molecules-19-02819]\]. *Tagetes* oil is used as a flavor component in food products including cola and alcoholic beverages, frozen dairy desserts, candy, baked goods, gelatins, puddings, condiments, and relishes \[[@B3-molecules-19-02819]\]. The oil has antibacterial \[[@B4-molecules-19-02819]\], larvicidal \[[@B5-molecules-19-02819]\], and insecticidal \[[@B6-molecules-19-02819]\] activities. Previous phytochemical studies of *T*. *minuta* L. led to the isolation of terpenes \[[@B2-molecules-19-02819],[@B7-molecules-19-02819]\], flavonoids \[[@B8-molecules-19-02819]\], thiophenes, and aromatic compounds \[[@B9-molecules-19-02819]\]. This article reports the isolation and characterization of two new compounds: 5-methyl-2,2\',5\',2\'\',5\'\',2\'\'\',5\'\'\',2\'\'\'\'-quinquethiophene (**1**) and quercetagetin-6-*O*-(6-*O*-caffeoyl-β-[d]{.smallcaps}-gluco-pyranoside) (**9**), together with seven known flavonoids ([Figure 1](#molecules-19-02819-f001){ref-type="fig"}).

![Chemical structures of the isolated compounds **1**--**9**.](molecules-19-02819-g001){#molecules-19-02819-f001}

2. Results and Discussion
=========================

Compound **1** was isolated as brown needles. HRESIMS gave an \[M+H\]^+^ at *m*/*z* 427.6611 and 428.6613 \[M+2H\]^+^, which is consistent with the molecular formula C~21~H~14~S~5~, implying fifteen degrees of unsaturation. The UV absorption maxima at 387 and 334 nm indicated the presence of quinquethiophene moiety \[[@B10-molecules-19-02819],[@B11-molecules-19-02819]\]. The ^1^H-NMR spectrum showed eleven protons signals at δ~H~ 6.64--7.21 with coupling constants 5.5--3.5 Hz characteristic for 5-subsituted quinquethiophenes \[[@B11-molecules-19-02819]\]. Additionally, the proton signal at δ~H~ 2.42 (3H, s) indicated the presence of a methyl group ([Table 1](#molecules-19-02819-t001){ref-type="table"}). The ^13^C-NMR spectrum exhibited twenty one carbon resonances. The multiplicities of the carbons in **1** were confirmed with DEPT and HSQC experiments, which showed one methyl, eleven methines, and nine quaternary carbons. ^1^H-^1^H COSY provided five spin systems for five thiophene rings ([Figure 2](#molecules-19-02819-f002){ref-type="fig"}). The HMBC spectrum exhibited cross peaks from methyl protons at C-5 to C-4 and C-5. In HMBC spectrum, cross-peaks from H-3 to C-2\', H-3\' to C-2, H-4\' to C-2\'\', H-3\'\' to C-5\', H-4\'\' to C-2\'\'\', H-3\'\'\' to C-5\'\', H-4\'\'\' to C-2\'\'\'\', and H-3\'\'\'\' to C-5\'\'\'confirmed the connectivity of thiophene rings \[[@B11-molecules-19-02819]\]. Accordingly, **1** was 5-methyl-2, 2\',5\', 2\'\',5\'\',2\'\'\',5\'\'\',2\'\'\'\'-quinquethiophene. Compound **1** was isolated for the first time from natural origin.
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###### 

NMR spectral data for compound **1** (CDCl~3~, 500 and 125 MHz).

  No.         δ~H~ \[mult., *J* (Hz)\]   δ~C~ (mult.)   HMBC
  ----------- -------------------------- -------------- --------------------------------------
  2           \-                         133.5 (C)      \-
  3           6.93 d (3.5)               125.9 (CH)     2, 4, 5
  4           6.64 brs                   124.0 (CH)     2, 3, 5
  5           \-                         137.3 (C)      \-
  2\'         \-                         134.2 (C)      \-
  3\'         6.97 d (3.5)               121.2 (CH)     2
  4\'         6.96 d (3.5)               122.3 (CH)     2\', 3\', 2\'\'
  5\'         \-                         128\. 9 (C)    \-
  2\'\'       \-                         134.7 (C)      \-
  3\'\'       6.98 d (3.5)               121.5 (CH)     4\'\'\', 2\'\'\'
  4\'\'       7.02 d (3.5)               122.3 (CH)     2\'\'\'
  5\'\'       \-                         126.1 (C)      \-
  2\'\'\'     \-                         135.1 (C)      \-
  3\'\'\'     6.99 d (3.5)               125.8 (CH)     4\'\'\', 5\'\'\', 2\'\'\'
  4\'\'\'     7.12 d (3.5)               121.6 (CH)     2\'\'\', 2\'\'\'\', 3\'\'\', 5\'\'\'
  5\'\'\'     \-                         132.8 (C)      \-
  2\'\'\'\'   \-                         135.3 (C)      \-
  3\'\'\'\'   7.04 brs                   122.5 (CH)     4\'\'\'\', 5\'\'\'
  4\'\'\'\'   7.14 brd (3.5)             121.7 (CH)     2\'\'\'\', 3\'\'\'\'
  5\'\'\'\'   7.21 brd (5.5)             123.0 (CH)     3\'\'\'\', 4\'\'\'\'
  5-CH~3~     2.42 s                     15.4 (CH~3~)   4, 5

![^1^H-^1^H COSY and HMBC correlations of **1** and **9**.](molecules-19-02819-g002){#molecules-19-02819-f002}

Compound **9** was isolated as a brown residue. It gave positive tests for flavonoids \[[@B12-molecules-19-02819]\]. The HRESIMS spectrum showed a pseudo-molecular ion peak at *m*/*z* 643.1223, consistent with a molecular formula C~30~H~26~O~16~. The UV spectrum of **9** showed absorption bands at 275 and 365 nm suggesting its flavonol nature \[[@B12-molecules-19-02819]\]. IR spectrum showed absorption bands at 3,460 (OH), 2,976 (aromatic C-H), 1,668 (ester C=O), 1,608 (*α*,*β*-unsaturated C=O), and 1,058 (C-O) cm^−1^. Analysis of the NMR spectra of **9** showed the presence of quercetagetin, *trans*-caffeoyl, and glucopyranosyl moieties and confirmed by significant fragment ion peaks at *m*/*z* 480.0826 \[M+H-caffeoyl\]^+^ and *m*/*z* 318.0299 \[M+H-(caffeoyl+hexose)\]^+^. The ^1^H-NMR spectrum revealed the presence of six singlets signals at δ~H~ 6.59 (H-8), 8.50 (3-OH), 9.35 (3\'-OH), 9.35 (4\'-OH), 10.89 (7-OH), and 12.24 (5-OH). Also, it showed three coupled protons at δ~H~ 6.88 (1H, d, *J* = 7.0 Hz, H-5\'), 7.57 (1H, brd, *J* = 7.0 Hz, H-6\'), and 7.74 (1H, brs, H-2\') for a *tri*-substituted B-ring ([Table 2](#molecules-19-02819-t002){ref-type="table"}). Furthermore, an anomeric proton signal at δ~H~ 5.02 (1H, d, *J* = 6.5 Hz, H-1\'\') indicated *β*-configuration of the glycosidic linkage \[[@B13-molecules-19-02819]\]. In addition, signals at δ~H~ 6.96 (1H, d, *J* = 1.5 Hz, H-2\'\'\'), 6.93 (1H, dd, *J* = 6.8, 1.5 Hz, H-6\'\'\' ), and 6.77 (1H, d, *J* = 6.8 Hz, H-5\'\'\') for a *tri*-substituted phenyl ring (ABX pattern) and two *trans*-coupled olefinic protons at δ~H~ 7.43 (1H, d, *J* = 16.0 Hz, H-7\'\'\') and 6.23 (1H, d, *J* = 16.0 Hz, H-8\'\'\') indicating the presence of *trans* caffeyol moiety ([Table 2](#molecules-19-02819-t002){ref-type="table"}) \[[@B14-molecules-19-02819],[@B15-molecules-19-02819],[@B16-molecules-19-02819]\] in which confirmed by ^13^C-NMR signals at δ~C~ 113.4 (C-8\'\'\'), 115.3 (C-5\'\'\'), 115.7 (C-2\'\'\'), 120.5 (C-6\'\'\'), 145.3 (C-4\'\'\'), 145.5 (C-7\'\'\'), 148.3 (C-3\'\'\'), and 166.5 (C-9\'\'\').
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###### 

NMR spectral data for compound **9** (DMSO-*d*~6~, 500 and 125 MHz).

  ----------------------------------------------------------------------------------------
  No.       δ~H~ \[mult., *J* (Hz)\]   δ~C~ (mult.)   HMBC
  --------- -------------------------- -------------- ------------------------------------
  2         \-                         148.1 (C)      \-

  3         \-                         135.6 (C)      \-

  4         \-                         176.1 (C)      \-

  5         \-                         151.5 (C)      \-

  6         \-                         129.6 (C)      \-

  7         \-                         151.4 (C)      

  8         6\. 59 s                   93.5 (CH)      6, 7, 10

  9         \-                         147.7 (C)      \-

  10        \-                         105.1 (C)      \-

  1\'       \-                         122.0 (C)      \-

  2\'       7.74 brs                   115.5 (CH)     2, 4\', 6\'

  3\'       \-                         145.0 (C)      \-

  4\'       \-                         147.5 (C)      \-

  5\'       6.88 d (7.0)               115.3 (CH)     3\', 6\'

  6\'       7.57 brd (7.0)             119.9 (CH)     2, 1\', 4\'

  1\'\'     5.02 d (6.5)               100.9 (CH)     6

  2\'\'     3.77 dd (7.0, 9.0)         73.1 (CH)      \-

  3\'\'     3.86 m                     75.7 (CH)      \-

  4\'\'     3.23 dd (9.0, 9.5)         69.6 (CH)      \-

  5\'\'     4.35 m                     77.2 (CH)      \-

  6\'\'     4.41 dd (2.8, 12.0)\       64.6 (CH~2~)   9\'\'\'
            4.30 dd (7.0, 12.0)                       

  1\'\'\'   \-                         125.2 (C)      \-

  2\'\'\'   6.96 d (1.5)               115.7 (CH)     6\'\'\', 7\'\'\'

  3\'\'\'   \-                         148.3 (C)      \-

  4\'\'\'   \-                         145.3 (C)      \-

  5\'\'\'   6.77 d (6.8)               115.3 (CH)     3\'\'\'

  6\'\'\'   6.93 dd (1.5, 6.8)         120.5 (CH)     4\'\'\', 5\'\'\', 7\'\'\', 8\'\'\'

  7\'\'\'   7.43 d (16.0)              145.5 (CH)     9\'\'\'

  8\'\'\'   6.23 d (16.0)              113.4 (CH)     1\'\'\', 9\'\'\'

  9\'\'\'   \-                         166.5 (C)      \-

  5-OH      12.24 s                    \-             \-

  7-OH      10.89 s                    \-             \-

  3\'-OH    9.35 s                     \-             \-

  4\'-OH    9.35 s                     \-             \-

  3-OH      8.50 s                     \-             \-
  ----------------------------------------------------------------------------------------

The ^13^C-NMR spectrum displayed fifteen carbon signals were attributed to quercetagetin skeleton \[[@B16-molecules-19-02819],[@B17-molecules-19-02819]\] and six carbons for glucose. The multiplicity of each carbon was determined by HSQC experiment. The glucose moiety was located at C-6 based on the HMBC cross peak of H-1\'\' at δ~H~ 5.02 (1H, d, *J* = 6.5 Hz) to C-6 (δ~C~ 129.6) and further confirmed by its reaction with diagnostic shift reagents. In the HMBC spectrum, the methylene protons at δ~H~ 4.41 (H-6\'\'B) and 4.30 (H-6\'\'A) correlated with the caffeoyl carbonyl group at δ~C~ 166.5 suggesting the connectivity of caffeoyl moiety at C-6\'\' and confirmed by the downfield shift of C-6\'\' (δ~C~ 64.6). Acid hydrolysis of **9** afforded quercetagetin, caffeic acid, and *β*-[d]{.smallcaps}-glucose. They were identified by co-chromatography with authentic samples using (S5) \[[@B14-molecules-19-02819]\]. Accordingly, **9** was identified as quercetagetin-6-*O*-(6-*O*-caffeoyl-β-[d]{.smallcaps}-glucopyranoside).

The other compounds were identified as quercetin-3,6-dimethyl ether (**2**) \[[@B18-molecules-19-02819]\], quercetin-3-methyl ether (**3**) \[[@B18-molecules-19-02819]\], quercetin (**4**) \[[@B18-molecules-19-02819]\], axillarin-7-*O*-*β*-[d]{.smallcaps}-glucopyranoside (**5**) \[[@B19-molecules-19-02819]\], quercetagetin-3,7-dimethoxy-6-*O*-*β*-[d]{.smallcaps}-glucopyranoside (**6**) \[[@B20-molecules-19-02819]\], quercetagetin-7-methoxy-6-*O*-*β*-[d]{.smallcaps}-glucopyranoside (**7**) \[[@B20-molecules-19-02819]\], and quercetagetin-6-*O*-*β*-[d]{.smallcaps}-glucopyranoside (**8**) \[[@B20-molecules-19-02819]\] by comparison of their physical and spectral data with those in the literature. The antioxidant activity of the isolated compounds **2**-**9** was determined by using a DPPH free radical scavenging system. The antioxidant percentage activity ranged from 91.6 to 68.3% ([Table 3](#molecules-19-02819-t003){ref-type="table"}). The antioxidant effect of these compounds was related to the number of free phenolic hydroxyl groups in the 3,4-dihydroxy form in their structures, which explains the close similarity of their antioxidant activity. Absence or blocking of the hydroxyl groups by a methyl or glucose moiety leads to a decrease of the antioxidant activity \[[@B21-molecules-19-02819]\].
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###### 

Antioxidant activity of the isolated compounds.

  Comp.   \% Activity
  ------- -------------
  2       81.1
  3       82.4
  4       91.6
  5       68.3
  6       69.1
  7       71.3
  8       83.0
  9       89.1

Compounds **1**--**9** were evaluated for their antimicrobial, antimalarial and antileishmanial activities. None of the isolated compounds **1**--**9** showed any antimicrobial activity. Compound **8** showed weak antileishmanial activity with an IC~50~ 31.0 μg/mL. Compound **3** showed moderate antimalarial activity against chloroquine sensitive (D6) clones of *P*. *falciparum* with an IC~50~ of 4.37 μg/mL.

3. Experimental
===============

3.1. General Procedures
-----------------------

Melting points were measured on an Electrothermal 9100 Digital Melting Point apparatus (Electrothermal Engineering Ltd, Essex, England). Optical rotation was measured with a Perkin-Elmer 241 automatic polarimeter (Perkin-Elmer Inc, Massachusetts, MA, USA). HRESIMS was recorded on a LTQ Orbitrap (ThermoFinnigan, Bremen, Germany) mass spectrometer. Low resolution mass spectra were determined using a Finnigan MAT TSQ-7000 mass spectrometer. UV spectra were recorded on a Shimadzu 1601 UV/VIS spectrophotometer (Kyoto, Japan). The IR spectra were measured on a Shimadzu Infrared-400 spectrophotometer. 1D and 2D NMR spectra were recorded on a Bruker Avance DRX 500 instrument (Bruker BioSpin, Massachusetts, MA, USA). Column chromatography separations were performed on silica gel 60 (0.04--0.063 mm), RP~18~ (0.04--0.063 mm Merck, Darmstadt, Germany), and Sephadex LH-20 (0.25--0.1 mm, Merck, Darmstadt, Germany). TLC was performed on pre-coated plates with silica gel 60 F~254~ (0.2 mm, Merck). The solvent systems used for TLC analyses were *n*-hexane/EtOAc (97:3, S1), CHCl~3~/MeOH (95:5, S2), CHCl~3~/MeOH (90:10, S3), CHCl~3~/MeOH (85:15, S4), and *n*-BuOH/HOAc/H~2~O (4:1:5, S5).

3.2. Plant Material
-------------------

The leaves of *Tagetes minuta* L. (Asteraceae) were collected in June 2012 from Al-Baha, Saudi Arabia. The plant was identified by Dr. A. A. Fayed, Prof. of Plant Taxonomy, Faculty of Science, Assiut University, Egypt. A voucher specimen (TM-1-2012) was deposited at the herbarium of the research center for medicinal, aromatic and poisonous plants, King Saud University.

3.3. Extraction and Isolation
-----------------------------

The air-dried powdered leaves (1.1 kg) were extracted with MeOH (4 × 5 L, 24 h each) at room temperature. The combined extracts were concentrated under reduced pressure to afford a dark green residue (30.8 g) which was suspended in distilled water (250 mL) then partitioned successively between *n*-hexane (3 × 500 mL), EtOAc (3 × 500 mL), and *n*-BuOH (3 × 500 mL). Each fraction was concentrated to give *n*-hexane (4.2 g), EtOAc (3.1 g), *n*-BuOH (2.6 g), and aqueous (17.8 g) fractions. The *n*-hexane fraction (4.2 g) was subjected to vacuum liquid chromatography (VLC) using a *n*-hexane-EtOAc gradient to afford four subfractions: H-1 to H-4. Subfraction H-1 (0.52 g) was chromatographed over a silica gel column (100 g × 50 × 2 cm) using *n*-hexane/EtOAc (99:1 to 90:10) to give **1** (17 mg, brown needles). The EtOAc fraction (3.1 g) was subjected to VLC using a CHCl~3~- MeOH gradient, to afford four subfractions: E-1 to E-4. Subfraction E-1 (0.69 g) was chromatographed over a silica gel column (100 g × 50 × 2 cm) using CHCl~3~-MeOH gradients to give **2** (12 mg, yellow needles) and **3** (17 mg, yellow needles). Subfraction E-2 (0.90 g) was similarly like subfraction E-1 to give **4** (9 mg, yellow needles). Silica gel column chromatography of subfraction E-3 (0.51 g) (150 g × 50 × 3 cm) using CHCl~3~-MeOH gradients yielded **5** (11 mg, yellow residue) and **6** (7 mg, yellow residue). Subfraction E-4 (0.81 g) was chromatographed over a Sephadex LH-20 column (100 g × 50 × 3 cm) using MeOH as an eluent to give two subfractions: E-4A (295 mg) and E-4B (430 mg). Subfraction E-4B was subjected to RP~18~ column chromatography (100 g × 50 × 2 cm) using a MeOH-H~2~O gradient to afford **7** (16 mg, yellow residue). The *n*-BuOH fraction (2.6 g) was subjected to Sephadex LH-20 column chromatography (100 g × 50 × 3 cm) using MeOH as an eluent to give three subfractions: B-1 (611 mg), B-2 (355 mg), and B-3 (760 mg). Separately, subfractions B-2 and B-3, each one was chromatographed over a RP~18~ column (40 g × 25 × 1 cm) using a MeOH-H~2~O gradient to give **8** (13 mg, yellow residue) and **9** (11 mg, brown residue). The other subfractions were retained for further investigation.

3.4. Spectral Data
------------------

*5-Methyl-2,2\',5\',2\',5\'\',2\'\'\',5\'\'\',2\'\'\'\'-quinquethiophene* (**1**). Brown needles (17 mg), m.p. 215--216 °C. R*~f~* 0.86, silica gel 60 F~254~ (S1). UV (MeOH): λ*~max~* 334, 387 nm. IR (KBr): *ν~max~* 2870, 1600 cm^−1^. NMR data: see [Table 1](#molecules-19-02819-t001){ref-type="table"}. HRESIMS: *m*/*z* 427.6611 (calcd for C~21~H~15~S~5~, \[M+H\]^+^, 427.6609); 428.6613 (calcd for C~21~H~16~S~5~, \[M+2H\]^+^, 428.6609).

*Quercetagetin-6-O-(6-O-caffeoyl-β-[d]{.smallcaps}-glucopyranoside)* (**9**). Brown residue (11 mg), R*~f~* 0.76, silica gel 60 F~254~ (S4). \[α\]~D~ −176 (0.5, MeOH). UV (MeOH): λ*~max~* 275, 365 nm; +NaOMe: 282, 405 nm; +AlCl~3~: 295, 410 nm; +AlCl~3~/HCl: 293 388 nm; +NaOAc: 296, 385 nm; +NaOAc/H~3~BO~3~: 280, 385 nm. IR (KBr): *ν~max~* 3460, 2976, 1668, 1608, 1565, 1058 cm^−1^. NMR data: see [Table 2](#molecules-19-02819-t002){ref-type="table"}. HRESIMS: *m*/*z* 643.1223 (calcd for C~30~H~27~O~16~, \[M+H\]^+^, 643.1221).

3.5. Acid Hydrolysis of **9**
-----------------------------

Compound **9** (3 mg) was refluxed in 10 mL of 1 N HCl for 4 h. The aglycone was extracted with CHCl~3~. The sugar in the aqueous layer was identified by co-paper chromatography (PC) with authentic materials using solvent system (S5) and aniline phthalate spray as detection reagent \[[@B14-molecules-19-02819]\].

3.6. Antimicrobial Assay
------------------------

All the isolated compounds **2**--**9** were tested for antimicrobial activity against *Candida albicans* ATCC 90028, *Candida glabrata* ATCC90030, *Candida krusei* ATCC 6258, *Asperigillus fumigates* ATCC 90906, methicillin-resistant *Staphylococcus aureus* ATCC 33591, *Cryptococcus neoformans* ATCC 90113, *Staphylococcus aureus* ATCC 2921, *Escherichia coli* ATCC 35218, *Pseudomonus aeruginosa* ATCC 27853, and *Mycobacterium intracellulare* ATCC 23068 as described previously \[[@B22-molecules-19-02819],[@B23-molecules-19-02819],[@B24-molecules-19-02819]\]. Ciprofloxacin and amphotericin B were used as positive standards.

3.7. Antimalarial Assay
-----------------------

The isolated compounds were tested on chloroquine sensitive (D6, Sierraleon) and resistant (W2, Indo-china) strains of *Plasmodium falciparum* using previously reported method \[[@B22-molecules-19-02819],[@B25-molecules-19-02819]\]. Artemisinin and chloroquine were included in each assay as anti-malarial drug controls.

3.8. Antileishmanial Assay
--------------------------

The anti-leishmanial activity of the isolated metabolites was tested *in vitro* against a culture of *L. donovani* promastigotes as previously outlined \[[@B26-molecules-19-02819]\]. Pentamidine and amphoterecin B were used as positive standards.

3.9. Antioxidant Activity
-------------------------

The antioxidant activity of the isolated compounds **2**--**9** (20 μM) in DPPH solution (4 mg was dissolved in HPLC MeOH 50 mL to obtain a concentration 80 μg/mL) was determined as previously outlined \[[@B27-molecules-19-02819],[@B28-molecules-19-02819],[@B29-molecules-19-02819]\].

4. Conclusions
==============

In conclusion, in this study nine compounds were isolated and elucidated from *T. minuta* L. two of them (compounds **1** and **9**) are new. The antioxidant, antimicrobial, antimalarial, and antileishmanial activities of the isolated compounds were evaluated. They showed antioxidant activity ranging from 91.6% to 68.3%. Compound **8** showed weak antileishmanial activity with an IC~50~ 31.0 μg/mL, while compound **3** showed moderate antimalarial activity against chloroquine sensitive (D6) clones of *P*. *falciparum* with an IC~50~ 4.37 μg/mL.
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